Entity family

Browse treatments

Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.

7,227articles mentioning treatments

16,644treatment mentions

4,719distinct treatments extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted treatments

Showing 541–600 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.

Locoregional therapy3 Pancreatic Enzyme Replacement Therapy3 Peroral endoscopic myotomy3 Pharmacologic treatment3 Positive Airway Pressure (PAP) therapy3 Regional analgesia3 Traditional Chinese Medicine3 Vitamin supplementation3 advanced therapies3 anti-PD1 therapy3 anti-VEGF therapy3 anti-programmed cell death protein-1 therapy3 antiarrhythmic therapy3 anticancer therapies3 anticancer therapy3 autologous stem cell transplantation3 behavioural therapy3 cancer therapies3 chimeric antigen receptor T-cell therapy3 clinical management3 cognitive–behavioural therapy3 conventional immunosuppression3 coronary revascularisation3 deworming3 diabetes treatment3 dopaminergic therapy3 haematopoietic stem cell transplantation3 immunotherapy treatment3 inhaled corticosteroids3 intensive care treatment3 intravenous fluid therapy3 intravenous iron therapy3 lethal palliation3 lifestyle changes3 local anaesthesia3 neurocritical care3 novel therapies3 nutritional support3 occupational therapy3 oral antibiotics3 outpatient treatment3 palliative chemotherapy3 pharmacological interventions3 physical rehabilitation3 preventive measures3 standard therapy3 standard treatment3 stent retriever thrombectomy3 supportive treatment3 surgical interventions3 surgical management3 symptomatic therapy3 targeted treatment3 topical therapy3 tracheostomy3 tyrosine kinase inhibitors3 ultrasound-guided nerve blocks3 vasodilator therapy3 vasopressors3 ventriculoperitoneal shunting3

View all 4,719 treatments on one page

Articles mentioning treatments

7,227 articles · page 589 of 603

1-032 Findings from a national patient experience survey of people affected by cardiomyopathy in the UK

heartjnl · abstract · 2025-08-13 · 1 matching annotations

79.4%

genetic testingConclusion cardiomyopathy NHS

…ndents said that they or the person they cared for were offered genetic testingConclusion There are some pockets of great care in UK cardiomyopathy healt…

2-002 Invasive coronary function testing changes management in patients with angina and unobstructed coronary arteries – an analysis of a multicentre experience in the UK

heartjnl · abstract · 2025-08-13 · 1 matching annotations

78.8%

stratified medical therapy ANOCA ANOCA-ve VSA MACE e-iCMD

…t endotyping has on long term management of these patients with stratified medical therapy. Little is known about the impact of either a positive or a neg…

2-022 Artifact-corrected artificial intelligence-LED intracoronary oct analysis identifies plaque progression and vulnerability, drug efficacy and patient events

heartjnl · abstract · 2025-08-13 · 1 matching annotations

81.8%

statin therapy coronary artery disease IBIS-4 MACE fibroatheroma

…t show regression of TCFA (C) or progression of ThCFA (D) after statin therapy. Fibrous caps are outlined in red.Abstract 2-022 Table 1Accurac…

2-025 Safe early discharge in post PCI (primary percutaneous intervention) ST-segment elevation myocardial infarction (STEMI )patients using ZWOLLE scoring system

heartjnl · abstract · 2025-08-13 · 1 matching annotations

80.2%

Percutaneous Coronary Intervention Northern General Hospital Barnsley Hospital Left Ventricular Systolic Dysfunction ST-Elevation Myocardial Infarction

…ified included delayed echocardiograms, complications post-PCI (Percutaneous Coronary Intervention) including severe Left Ventricular Systolic Dysfunction. The ac…

2-030 Prevalence of high bleeding risk patients undergoing percutaneous coronary intervention, their clinical outcomes and the application of a bleeding versus thrombotic risk trade-off calculator in a real-world NHS cohort

heartjnl · abstract · 2025-08-13 · 1 matching annotations

77.6%

PCI acute coronary syndrome

…kground Patients undergoing percutaneous coronary intervention (PCI) are at risk of developing bleeding and/or thrombotic complicat…

2-035 Pre-hospital stratification of out of hospital cardiac arrest – the pre-MIRACLE2 score

heartjnl · abstract · 2025-08-13 · 1 matching annotations

76.0%

cardiovascular therapies OHCA

…f patients for direct conveyance to a cardiac arrest centre for cardiovascular therapies, reducing unnecessary inter-hospital transfers with the potenti…

2-038 Dilemma of aspirin use in coronary vessel disease in G6PD: an interesting case report and consideration in practice

heartjnl · abstract · 2025-08-13 · 1 matching annotations

76.4%

DAPT aspirin G6PD deficiency

…gativenegative Haptoglobin (0.35–2.5 g/l)2.292.482.59Conclusion DAPT is considered essential following PCI. The use of antiplatelet …

2-039 The impact of socioeconomic deprivation on NSTEMI mortality: insights from 437,024 PCI patients in the BCIS registry

heartjnl · abstract · 2025-08-13 · 1 matching annotations

77.4%

percutaneous coronary intervention NSTEMI ST-segment elevation myocardial infarction British Cardiovascular Intervention Society STEMI non-ST elevation myocardial infarction

…is study evaluates whether universal healthcare ensures optimal percutaneous coronary intervention (PCI) outcomes across different SES groups and highlights poten…

2-053 Optimising catheter lab efficiency with non-invasive cardiac testing for stable chest pain patients: a quality improvement project

heartjnl · abstract · 2025-08-13 · 1 matching annotations

76.0%

revascularisation NICE chronic coronary syndromes chest pain

… symptom resolution by 8 months, highlighting the importance of revascularisation as a treatment strategy for chronic coronary syndromes.…

2-054 Impact of demographics on door-to-balloon time in self-presenting STEMI patients at a non-PCI centre in North Wales

heartjnl · abstract · 2025-08-13 · 1 matching annotations

77.5%

PPCI ST-elevation myocardial infarction STEMI PCI centre Non-PCI centre Myocardial Ischaemia National Audit Project

…t delays significantly impact outcomes. UK guidelines recommend PPCI within 120 minutes of diagnosis. While demographic disparities …

2-057 An analysis of differences in discharge medications following STEMI by ethnicity: a single-centre retrospective study

heartjnl · abstract · 2025-08-13 · 1 matching annotations

76.3%

guideline-directed pharmacotherapy aspirin P2Y12 inhibitors ST-elevation MI (STEMI)Barts Health NHS Trust statins Myocardial infarction beta-blockers

…re, this analysis revealed an equitable approach to prescribing guideline-directed pharmacotherapy in STEMI patients at discharge, across different ethnicities. F…

2-060 Biomechanics parameter improves outcome prediction and patient selection for fetal aortic valvuloplasty

heartjnl · abstract · 2025-08-13 · 1 matching annotations

78.9%

Fetal aortic valvuloplasty Fetal critical aortic stenosis hypoplastic left heart syndrome CAS-eHLHS

…progression to hypoplastic left heart syndrome (HLHS) at birth. Fetal aortic valvuloplasty (FAV) can resolve the flow obstruction, and past studies sugges…